18 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
, the Company announced the presentation of a peer-reviewed abstract that was presented on November 4, 2022 at the American Society of Nephrology … at the American Society of Nephrology meeting held November 2022 and added further new evidence to support our belief that XOI produced by our proprietary
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
, 2022, the Company announced the presentation of a peer-reviewed abstract that was presented on November 4, 2022 at the American Society of Nephrology … at the American Society of Nephrology meeting held November 2022 and added further new evidence to support our belief that XOI produced by our
6-K
EX-99.1
XRTX
XORTX Therapeutics Inc
2 Nov 23
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023
7:00am
EXHIBIT 99.1
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023
Preclinical Findings Help Clarify … to treat progressive kidney disease, is pleased to announce the presentation of new research findings at the American Society of Nephrology meeting
6-K
EX-99.1
XRTX
XORTX Therapeutics Inc
28 Sep 23
XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023
7:56am
EXHIBIT 99.1
XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023
CALGARY, Alberta, Sept. 28 … submitted to the American Society of Nephrology (the “ASN”). The abstract entitled "The Effect of Lowering Uric Acid with a Xanthine Oxidase Inhibitor
6-K
EX-99.2
87kz4vavj5
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.3
z2h 5iuq9jcw
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.1
lktdemcd2 ou
8 Dec 22
Independent Study Shows Moderate Dose Strength of XORLO™ Attenuates Kidney Expansion
7:00am
424B3
l46w5 c5agnpnu5t4s
14 Nov 22
Prospectus supplement
1:51pm
6-K
EX-99.2
twxhj6ujevq
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
6-K
EX-99.1
aqh0ds6ika
3 Nov 22
XORTX Presents New Proof of Concept Data at American Society of Nephrology
5:01pm
6-K
EX-99.1
c7gs h7i70pzwz7z1w
25 Oct 22
Current report (foreign)
7:12am
6-K
EX-99.1
dabtrye the1
1 Sep 22
XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2022
8:10am
6-K
EX-99.1
z5a z91nxef
31 Jan 22
XORTX Provides Corporate Update
7:00am
6-K
EX-99.2
00cy709bqahmf1 loqvc
10 Jan 22
XORTX to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference
7:01am
DRS
EX-10.8
xmv zvm27bxsw314t8h
26 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next